Cargando…
First-in-Human Percutaneous Transcatheter Tricuspid Valve Replacement With a Novel Valve
The surgical intervention to treat isolated severe tricuspid regurgitation (TR) is challenging due to the severe TR patients’ high-risk profile, hence associated with a high complication rate. Herein, we describe a first-in-human percutaneous deployment of a novel transcatheter prosthetic xenograft...
Autores principales: | Vaturi, Mordehay, Vaknin-Assa, Hana, Shapira, Yaron, Perl, Leor, Levi, Amos, Koren, Arnon, Kornowski, Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387838/ https://www.ncbi.nlm.nih.gov/pubmed/34471878 http://dx.doi.org/10.1016/j.jaccas.2021.06.014 |
Ejemplares similares
-
Tricuspid Structural Valve Deterioration Treated with a Transcatheter Valve-in-Valve Implantation: A Single-Center Prospective Registry
por: Schamroth Pravda, Nili, et al.
Publicado: (2022) -
5 Year Outcomes of Patients With Aortic Structural Valve Deterioration Treated With Transcatheter Valve in Valve – A Single Center Prospective Registry
por: Schamroth Pravda, Nili, et al.
Publicado: (2021) -
Five-Year Outcomes of Patients With Mitral Structural Valve Deterioration Treated With Transcatheter Valve in Valve Implantation – A Single Center Prospective Registry
por: Schamroth Pravda, Nili, et al.
Publicado: (2022) -
Outcomes of Transcatheter Edge-to-Edge Repair in Degenerative vs. Functional Mitral Regurgitation
por: Kheifets, Mark, et al.
Publicado: (2022) -
Trends in Ischemic Mitral Regurgitation Following ST-Elevation Myocardial Infarction Over a 20-Year Period
por: Perl, Leor, et al.
Publicado: (2022)